Researchers conducting early medical trials found that daily daraxonrasib combined with chemotherapy stopped tumors growing in almost all 61 participants with recently diagnosed advanced pancreatic cancer that had spread. Cancer became undetectable on scans in one in 12 patients; a separate account said the combination produced tumor responses in 60.7%, including five patients with no detectable tumors. Doctors said durability is unclear and it is not a cure.
2 reports from 2 publishers confirmed as covering this specific event.
Reporting from 2 identified publishers across this event arc.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 137 of 23108
Same format. Every time.
Continue reading — sign in or create a free account with